Ancora Advisors’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,600
Closed -$35K 2727
2021
Q4
$35K Hold
3,600
﹤0.01% 1407
2021
Q3
$35K Buy
3,600
+2,100
+140% +$20.2K ﹤0.01% 1307
2021
Q2
$14K Buy
+1,500
New +$14.7K ﹤0.01% 1461

Other funds holding MSAC

Ancora Advisors's MSAC Position: Q1 2022 in Review

Ancora Advisors sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2022, closing a stake of 3,600 shares — an estimated $35K sold.

Ancora Advisors first reported a position in MSAC in Q2 2021 and held it in 3 quarters. The position peaked at $35K in Q4 2021. 54 funds tracked by Wall St. Rank hold MSAC as of Q1 2022.

  • Ancora Advisors reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2022 after selling out during the quarter.
  • Ancora Advisors sold 3,600 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2022, an estimated $35K.
  • Ancora Advisors first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 3 quarters.
  • Ancora Advisors's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $35K in Q4 2021.
  • 54 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2022.

Based on Ancora Advisors's 13F filing for Q1 2022, filed 13 May 2022.